Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Center-level trends in utilization of HCV-exposed donors for HCV-uninfected kidney and liver transplant recipients in the United States
Mary G. Bowring, Ashton A. Shaffer, Allan B. Massie, et al.
American Journal of Transplantation (2019) Vol. 19, Iss. 8, pp. 2329-2341
Open Access | Times Cited: 43

Showing 1-25 of 43 citing articles:

Assessing Solid Organ Donors and Monitoring Transplant Recipients for Human Immunodeficiency Virus, Hepatitis B Virus, and Hepatitis C Virus Infection — U.S. Public Health Service Guideline, 2020
Jefferson M. Jones, Ian Kracalik, Marilyn E. Levi, et al.
MMWR Recommendations and Reports (2020) Vol. 69, Iss. 4, pp. 1-16
Open Access | Times Cited: 98
National Trends in Utilization and 1-Year Outcomes with Transplantation of HCV-Viremic Kidneys
Vishnu S. Potluri, David S. Goldberg, Sumit Mohan, et al.
Journal of the American Society of Nephrology (2019) Vol. 30, Iss. 10, pp. 1939-1951
Open Access | Times Cited: 72
Utilization of hepatitis C virus–infected organ donors in cardiothoracic transplantation: An ISHLT expert consensus statement
Saima Aslam, Paolo Grossi, Kelly Schlendorf, et al.
The Journal of Heart and Lung Transplantation (2020) Vol. 39, Iss. 5, pp. 418-432
Closed Access | Times Cited: 65
Beyond donation to organ utilization in the USA
Darren Stewart, Richard Hasz, Bonnie E. Lonze
Current Opinion in Organ Transplantation (2023) Vol. 28, Iss. 3, pp. 197-206
Closed Access | Times Cited: 16
Cost-effectiveness of Using Kidneys From HCV-Viremic Donors for Transplantation Into HCV-Uninfected Recipients
Mark H. Eckman, E. Steve Woodle, Charuhas V. Thakar, et al.
American Journal of Kidney Diseases (2020) Vol. 75, Iss. 6, pp. 857-867
Closed Access | Times Cited: 32
Trends in Discard of Kidneys from Hepatitis C Viremic Donors in the United States
Su‐Hsin Chang, Massini Merzkani, Krista L. Lentine, et al.
Clinical Journal of the American Society of Nephrology (2021) Vol. 16, Iss. 2, pp. 251-261
Open Access | Times Cited: 25
Examining Differential Transplantation Rates and Outcomes by Center Volume During Weekend and Holidays
John R. Montgomery, Martha M Estrada, Raj B. Patel, et al.
Current Transplantation Reports (2025) Vol. 12, Iss. 1
Closed Access
Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy
Christine Chan, Thomas D. Schiano, Eliana Z. Agudelo, et al.
American Journal of Transplantation (2018) Vol. 18, Iss. 10, pp. 2506-2512
Open Access | Times Cited: 31
Survey of Clinician Opinions on Kidney Transplantation from Hepatitis C Virus Positive Donors: Identifying and Overcoming Barriers
Krista L. Lentine, John Devin Peipert, Tarek Alhamad, et al.
Kidney360 (2020) Vol. 1, Iss. 11, pp. 1291-1299
Open Access | Times Cited: 27
Commercial insurance delays direct‐acting antiviral treatment for hepatitis C kidney transplantation into uninfected recipients
Julia Torabi, Juan P. Rocca, Maria Ajaimy, et al.
Transplant Infectious Disease (2020) Vol. 23, Iss. 1
Closed Access | Times Cited: 24
Utilization of Hepatitis B viremic donors (NAT+) leads to improved kidney transplant access for older adult recipients with little to no wait time
Reynold I. Lopez‐Soler, Cara Joyce, Laura Cotiguala, et al.
Transplant Infectious Disease (2024) Vol. 26, Iss. 3
Open Access | Times Cited: 2
Lessons from the real world: HCV-infected donor kidney transplantation as standard practice
Christine M. Durand, Michael A. Chattergoon, Niraj M. Desai
American Journal of Transplantation (2019) Vol. 19, Iss. 11, pp. 2969-2970
Open Access | Times Cited: 18
A review of kidney transplantation from HCV-viremic donors into HCV-negative recipients
Reem Daloul, Todd E. Pesavento, David S. Goldberg, et al.
Kidney International (2021) Vol. 100, Iss. 6, pp. 1190-1198
Closed Access | Times Cited: 13
Utilization of HCV viremic donors in kidney transplantation: a chance or a threat?
Paulina Czarnecka, Kinga Czarnecka, Olga Tronina, et al.
Renal Failure (2022) Vol. 44, Iss. 1, pp. 434-449
Open Access | Times Cited: 9
Race, Education, and Gender Disparities in Transplantation of Kidneys From Hepatitis C Viremic Donors
Tiffany Nguyen, Meghan E. Sise, Cindy Delgado, et al.
Transplantation (2020) Vol. 105, Iss. 8, pp. 1850-1857
Open Access | Times Cited: 13
Center-level Utilization of Hepatitis C Virus–positive Donors for Orthotopic Heart Transplantation
Lauren V. Huckaby, Laura Seese, Robert Handzel, et al.
Transplantation (2021) Vol. 105, Iss. 12, pp. 2639-2645
Open Access | Times Cited: 11
Hepatitis C–associated focal proliferative glomerulonephritis in an aviremic recipient of a hepatitis C–positive antibody donor liver
Humberto Bohórquez, Juan Carlos Q. Velez, Mark A. Lusco, et al.
American Journal of Transplantation (2021) Vol. 21, Iss. 8, pp. 2895-2899
Open Access | Times Cited: 11
The Spread Pattern of New Practice in Liver Transplantation in the United States
Miho Akabane, Yuki Imaoka, Carlos O. Esquivel, et al.
Clinical Transplantation (2024) Vol. 38, Iss. 7
Closed Access | Times Cited: 1
Updated View on Kidney Transplant from HCV-Infected Donors and DAAs
Fabrizio Fabrizi, Roberta Cerutti, Carlo Alfieri, et al.
Pharmaceutics (2021) Vol. 13, Iss. 4, pp. 496-496
Open Access | Times Cited: 10
Regional Differences and Temporal Changes in the Utilization of HCV-Viremic Donors in Kidney Transplantation
Napat Leeaphorn, Rose Mary Attieh, Hani M. Wadei, et al.
Transplantation Proceedings (2024) Vol. 56, Iss. 6, pp. 1513-1521
Closed Access | Times Cited: 1
Follow‐up post‐HCV virological response to DAA in advanced chronic liver disease
Antonietta Romano, N. Zeni, A.R. Caspanello, et al.
Liver International (2024)
Closed Access | Times Cited: 1
Classification of Medical Datasets Using Optimal Feature Selection Method with Multi-support Vector Machine
S. Silvia Priscila, Chandan Kumar
Communications in computer and information science (2022), pp. 220-232
Closed Access | Times Cited: 6
Temporal changes in the utilization of kidneys from hepatitis C virus–infected donors in the United States
Keri-Ann Buchanan-Peart, Javier Pagán, Éric Martin, et al.
American Journal of Transplantation (2023) Vol. 23, Iss. 6, pp. 831-838
Open Access | Times Cited: 3
Lung transplant recipient attitudes and beliefs on accepting an organ that is positive for hepatitis C virus
Sapna S. Humar, Natalia Pinzon, Marcelo Cypel, et al.
Transplant Infectious Disease (2021) Vol. 23, Iss. 4
Closed Access | Times Cited: 7
Donors with human immunodeficiency virus and hepatitis C virus for solid organ transplantation: what's new
Stephanie A. Lushniak, Christine M. Durand
Current Opinion in Infectious Diseases (2022) Vol. 35, Iss. 4, pp. 321-329
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top